DKK1 and ankylosing spondylitis: Similarly, Wnt signaling inhibitors sclerostin and DKK-1 have been investigated as biomarkers for disease activity in ankylosing spondylitis (AS), and a lower level of serum DKK-1 was observed in AS patients [39, 60].